Get email alerts when AVTX insiders make a move — free, no credit card

AVTX Insider Trading & Form 4 Activity

Avalo Therapeutics, Inc.
Last filing: Jun 1, 2026·9 days ago
NEUTRAL · LAST 90 DAYS
0%
buyers
$0
0 buys
$0
0 sells
$0
net buying
0
insiders
Tracking AVTX insiders takes 3 seconds. Get free alerts →

Net flow — last 12 months

Monthly net of insider buys minus sells. Green months indicate net buying; red months indicate net selling.

Most active insiders

Ranked by total transaction value over the last 90 days.

INSIDERBOUGHTSOLDNET
Doyle Mittie
Chief Medical Officer
$2.3M
-$2.3M
VARKI PAUL
Chief Legal Officer
$1.5M
-$1.5M
Sullivan Christopher Ryan
Chief Financial Officer
$1.4M
-$1.4M
Chan Mitchell
Director
$72K
-$72K
Riley Jennifer
Chief Strategy Officer
$0
NEIL GARRY ARTHUR
Chief Executive Officer
$0

Recent transactions

Every Form 4 transaction for AVTX, newest first.

SELL10b5-1
Doyle Mittie · Chief Medical Officer
Tx May 28·Filed Jun 1·EDGAR ↗
679 sh @ $16.00
$11K
EXERCISE10b5-1
Doyle Mittie · Chief Medical Officer
Tx May 28·Filed Jun 1·EDGAR ↗
679 sh @ $8.04
$5K
AWARD
Riley Jennifer · Chief Strategy Officer
Tx May 21·Filed May 26·EDGAR ↗
34,200 sh
AWARD
Sullivan Christopher Ryan · Chief Financial Officer
Tx May 21·Filed May 26·EDGAR ↗
39,900 sh
AWARD
VARKI PAUL · Chief Legal Officer
Tx May 21·Filed May 26·EDGAR ↗
24,300 sh
AWARD
NEIL GARRY ARTHUR · Chief Executive Officer
Tx May 21·Filed May 26·EDGAR ↗
100,200 sh
AWARD
Doyle Mittie · Chief Medical Officer
Tx May 21·Filed May 26·EDGAR ↗
43,500 sh
EXERCISE10b5-1
Doyle Mittie · Chief Medical Officer
Tx May 15·Filed May 19·EDGAR ↗
3,000 sh @ $12.65
$38K
SELL10b5-1
Doyle Mittie · Chief Medical Officer
Tx May 15·Filed May 19·EDGAR ↗
3,000 sh @ $18.76
$56K
EXERCISE10b5-1
Sullivan Christopher Ryan · Chief Financial Officer
Tx May 7·Filed May 11·EDGAR ↗
18,606 sh @ $9.88
$184K
SELL10b5-1
Sullivan Christopher Ryan · Chief Financial Officer
Tx May 7·Filed May 11·EDGAR ↗
18,606 sh @ $24.12
$449K
EXERCISE10b5-1
VARKI PAUL · Chief Legal Officer
Tx May 6·Filed May 7·EDGAR ↗
62,500 sh @ $13.43
$839K
SELL10b5-1
Sullivan Christopher Ryan · Chief Financial Officer
Tx May 6·Filed May 7·EDGAR ↗
2,700 sh @ $20.76
$56K
SELL10b5-1
Sullivan Christopher Ryan · Chief Financial Officer
Tx May 6·Filed May 7·EDGAR ↗
9,219 sh @ $21.37
$197K
SELL10b5-1
Sullivan Christopher Ryan · Chief Financial Officer
Tx May 6·Filed May 7·EDGAR ↗
8,900 sh @ $22.57
$201K
SELL10b5-1
Chan Mitchell · Director
Tx May 6·Filed May 7·EDGAR ↗
3,167 sh @ $22.88
$72K
SELL10b5-1
VARKI PAUL · Chief Legal Officer
Tx May 6·Filed May 7·EDGAR ↗
37,375 sh @ $18.91
$707K
EXERCISE10b5-1
VARKI PAUL · Chief Legal Officer
Tx May 6·Filed May 7·EDGAR ↗
12,563 sh @ $8.04
$101K
SELL10b5-1
Sullivan Christopher Ryan · Chief Financial Officer
Tx May 6·Filed May 7·EDGAR ↗
12,347 sh @ $19.28
$238K
EXERCISE10b5-1
Doyle Mittie · Chief Medical Officer
Tx May 6·Filed May 7·EDGAR ↗
77,905 sh @ $12.65
$985K
EXERCISE10b5-1
Doyle Mittie · Chief Medical Officer
Tx May 6·Filed May 7·EDGAR ↗
28,650 sh @ $8.04
$230K
SELL10b5-1
Doyle Mittie · Chief Medical Officer
Tx May 6·Filed May 7·EDGAR ↗
27,538 sh @ $18.03
$496K
SELL10b5-1
Doyle Mittie · Chief Medical Officer
Tx May 6·Filed May 7·EDGAR ↗
5,000 sh @ $19.65
$98K
SELL10b5-1
Doyle Mittie · Chief Medical Officer
Tx May 6·Filed May 7·EDGAR ↗
44,944 sh @ $21.20
$953K
SELL10b5-1
Doyle Mittie · Chief Medical Officer
Tx May 6·Filed May 7·EDGAR ↗
19,015 sh @ $22.41
$426K
SELL10b5-1
Doyle Mittie · Chief Medical Officer
Tx May 6·Filed May 7·EDGAR ↗
10,058 sh @ $22.88
$230K
SELL10b5-1
Sullivan Christopher Ryan · Chief Financial Officer
Tx May 6·Filed May 7·EDGAR ↗
13,834 sh @ $18.55
$257K
EXERCISE10b5-1
Sullivan Christopher Ryan · Chief Financial Officer
Tx May 6·Filed May 7·EDGAR ↗
47,000 sh @ $8.04
$378K
SELL10b5-1
VARKI PAUL · Chief Legal Officer
Tx May 6·Filed May 7·EDGAR ↗
400 sh @ $23.71
$9K
SELL10b5-1
VARKI PAUL · Chief Legal Officer
Tx May 6·Filed May 7·EDGAR ↗
9,253 sh @ $22.70
$210K
SELL10b5-1
VARKI PAUL · Chief Legal Officer
Tx May 6·Filed May 7·EDGAR ↗
22,839 sh @ $21.22
$485K
SELL10b5-1
VARKI PAUL · Chief Legal Officer
Tx May 6·Filed May 7·EDGAR ↗
5,196 sh @ $19.78
$103K
EXERCISE10b5-1
Doyle Mittie · Chief Medical Officer
Tx May 5·Filed May 7·EDGAR ↗
1,000 sh @ $12.65
$13K
EXERCISE10b5-1
Doyle Mittie · Chief Medical Officer
Tx May 5·Filed May 7·EDGAR ↗
679 sh @ $8.04
$5K
SELL10b5-1
Doyle Mittie · Chief Medical Officer
Tx May 5·Filed May 7·EDGAR ↗
1,679 sh @ $16.00
$27K

Track every ticker you care about

Free plan includes 3 tickers, daily insider scans, and cluster alerts. No credit card.

Start free (3 tickers)See plans

Join investors tracking SEC filings.

About AVTX insider trading data

Form 4 is the SEC filing required when an officer, director, or 10% owner of a public company buys or sells the company's stock. By law, these filings must be submitted within two business days of the trade. Tracenotes pulls every Form 4 filing for AVTX from EDGAR, parses it, and surfaces the activity on this page.

What insider buying tells you. Open-market purchases by insiders are widely studied as a meaningful signal. Unlike stock awards (which are compensation, not conviction), an executive spending their own money to buy shares of the company they run is a vote of confidence. Studies have found insider-buying clusters — three or more insiders buying within a short window — outperform the broader market over the following year.

What insider selling tells you. Selling is noisier. Many sales are pre-scheduled under SEC Rule 10b5-1 plans, which let insiders sell on a fixed schedule regardless of company news. We label these "10b5-1" so you can see them. Discretionary sales — sales not tied to a plan — are more meaningful, especially when multiple insiders sell in quick succession.

Tracenotes methodology. We scan EDGAR daily for new Form 4 filings, parse them into individual transactions, and detect clusters when three or more distinct insiders buy or sell within a 14-day window. The data on this page covers the last 12 months. For deeper analysis, Tracenotes also runs language-change detection on 10-K and 10-Q filings — that's our core product.

See this for every ticker.

Tracenotes covers the S&P 500 and beyond. Pick any ticker — get the same depth of insider trading data.

AAPLNVDAMSFTTSLA

Free plan available — no credit card. Sign up free →

Frequently asked questions

What is a Form 4 filing?

Form 4 is the SEC disclosure required when a company insider — an officer, director, or 10% owner — buys or sells the company's stock. By law these filings must be submitted within two business days of the trade.

Is insider buying AVTX always bullish?

Open-market purchases by insiders are widely viewed as a bullish signal because executives are spending their own money. Stock awards and option exercises are part of compensation and don't carry the same weight, which is why we treat them separately on this page.

What is a 10b5-1 trade?

A trade made under SEC Rule 10b5-1, which lets insiders pre-schedule sales weeks or months in advance. These sales execute on a fixed plan regardless of company news, so they're a weaker signal than discretionary sales. We label them with a "10b5-1" tag.

What is an insider cluster?

A cluster is when three or more distinct insiders buy or sell within a 14-day window. Clusters are studied as stronger signals than single trades because multiple people independently reach the same view. We surface active clusters on Avalo Therapeutics, Inc. (AVTX) when they form.

Where does AVTX insider trading data come from?

Every Form 4 filing for AVTX is sourced directly from SEC EDGAR. Tracenotes scans EDGAR daily, parses each Form 4 into individual transactions, and updates this page within hours of new filings.

Nothing on this page constitutes investment advice. Form 4 data is sourced from SEC EDGAR and provided for research purposes only.

© 2026 Tracenotes · tracenotes.ai